Ancient gut therapy takes on allergies in new clinical trial
NCT ID NCT07626099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an Ayurvedic treatment that targets digestion and gut health can reduce allergy symptoms and immune markers in people with allergic rhinitis (hay fever). 104 adults aged 18-40 with confirmed allergies will receive either the Ayurvedic treatment plus standard care, or standard care alone. The main goal is to measure changes in immune markers and gut permeability over 4 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 104 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2028
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
\*\*Inclusion Criteria:\*\* * Participants aged 18-40 years. * Clinical diagnosis of Allergic Rhinitis based on standard diagnostic criteria. * Positive skin prick test to relevant allergens. * Presence of active allergic rhinitis symptoms at the time of recruitment. * Willingness to participate and provide written informed consent. * Willingness to comply with study procedures, laboratory investigations, and follow-up assessments. \*\*Exclusion Criteria:\*\* * Severe systemic illness. * Immunodeficiency disorders. * Autoimmune diseases. * Chronic gastrointestinal disorders that may influence gut permeability parameters. * Other chronic inflammatory conditions that may influence immune response. * Long-term immunosuppressive therapy. * Systemic corticosteroid therapy. * Biologic therapy. * Use of medications known to significantly alter immune response or gut microbiota. * Use of antibiotics within the previous 3 months. * Use of probiotics within the previous 3 months. * Use of prebiotics within the previous 3 months. * Pregnancy. * Lactation. * Known food allergy or hypersensitivity to study medications. * Severe psychiatric illness. * Inability to comply with study procedures. * Current participation in another clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Allergic rhinitis (AR) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.